While mononeuropathy multiplex is not the most prevalent symptom associated with EGPA, it manifests in approximately 75% of cases and is more frequent in ANCA-MPO-positive EGPA compared to cases where these antibodies are negative. The gene discussed is MPO; the disease is eosinophilic granulomatosis with polyangiitis.